I know you are a very long term holder and very knowledgable, and always like reading your posts, but I can't see how if Invion has something special that big pharma really want, how an offer hasn't been made by now. If it was really special, surely a pharma would want to get in early and try for a cheap partnering or takeover offer, rather than wait for positive results or even a ph3. There's been a couple of recent examples of partnering prior to release of ph2 results. I'm back in this for a small amount for a punt, because I think it's ridiculously cheap, and downside risk of negative results has largely passed for now, but cash burn and dilution risk is very real, and has been continuously overlooked by all who have been long term shareholders of this company. I reckon many are praying for a white knight
IVX Price at posting:
1.5¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)